Publication | Open Access
CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
30
Citations
32
References
2021
Year
Our findings suggest that CD9 is a new biomarker of AML LSCs and is a promising therapeutic target.
| Year | Citations | |
|---|---|---|
Page 1
Page 1